-

Cresco Labs Expands Sunnyside in Pennsylvania with 11th New Store

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced its retail footprint grew to 57 locations nationwide with today’s Sunnyside opening in Erie, PA. Sunnyside Erie, located at 7851 Peach St., marks the Company’s 11th dispensary in the state.

“We’re thrilled to build on our retail and wholesale success in Pennsylvania by expanding the Sunnyside brand in northern Pennsylvania,” said Charles Bachtell, Cresco Labs’ CEO & Co-Founder. “We’ve maintained our position in the state as the number one branded portfolio chosen by medical patients for all of 2022. With licenses to open four additional stores, we’ll continue to go deep in Pennsylvania to increase patient access to our top-quality products.”

Sunnyside Erie is the Company’s first dispensary in Pennsylvania to offer a drive through to give medical patients a safe and more convenient way to shop. The dispensary is strategically located in a major retail corridor near big box retailers like Walmart and Home Depot and off Interstate 90 for increased accessibility.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Sunday through Thursday, 9 AM to 6 PM, and Friday and Saturday, 9 AM to 7 PM.

Cresco Labs operates 11 Sunnyside stores in Pennsylvania: Butler, Philadelphia (Chestnut St. and City Ave.), New Kensington, Pittsburgh, Wyomissing, Ambler, Lancaster, Phoenixville, Montgomeryville and Erie.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Twitter: Cresco Labs

LinkedIn: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Summary
Cresco Labs Expands Sunnyside in Pennsylvania with 11th New Store
Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Social Media Profiles
More News From Cresco Labs

Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with ke...

Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank

CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs’ disciplined growth and consolidation strategy....

Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances...
Back to Newsroom